


Arf Bio Renewable Energy stands out as a significant player in Turkey's renewable energy sector. The company's IPO has been approved by the Capital Markets Board (CMB) and is expected to offer attractive opportunities for investors.
Founded in 2015 in Ankara, Arf Bio began producing electricity with its first investment, a 5.7 MW solar power plant in the Kadınhanı district of Konya. Following this, an important step was taken in the biomass field with the Ödemiş Biogas Power Plant. With a capacity of 4.8 MW, this plant has the potential to meet the electricity needs of 35,000 people daily.
The IPO price of Arf Bio Renewable Energy has been set at 19.50 TL. The scale of the IPO is planned to be 916 million TL. A total of 47 million shares will be distributed, and the free float ratio will be 25.71%.
As of 2023, the company has reported a revenue of 272.82 million TL and a net profit of 101.19 million TL. The proceeds from the IPO will be used for areas such as 15-20% micro algae investment, 20-25% greenhouse investment, and 20-25% repayment of financial and current debts. However, price stability post-IPO is not planned.
The IPO is expected to occur through equal distribution to individuals. Whether Arf Bio is eligible for the participation index will be clarified after the prospectus is published. Investors can evaluate based on the innovative investments and growth strategies undertaken by the company.
```.png)
Sizlere kesintisiz haber ve analizi en hızlı şekilde ulaştırmak için. Yakında tüm platformlarda...